The Role of Third-Generation TKIs in Overcoming Chronic Myeloid Leukemia Resistance
ONCOLife
SUNMO Trial: A New Chapter for Transplant-Ineligible Large B-Cell Lymphoma
The V Foundation for Cancer Research and CVC Partner to Accelerate Breast Cancer Vaccines
Advancing ADCs and Bispecifics Across Oncology and Immunology
Shining a Light on Lung Cancer: The Promise of Abenacianine
Webinar
How to Improve Access to CAR T-cell Therapy: The Role of Policy and Innovation
Overcoming Challenges and Expanding Access to CAR T-Cell Therapy
A Patient Advocacy Perspective on Expanding Access to CAR T-cell Therapy
MB-105 CAR-T Therapy: Advancing Precision Treatment for CD5+ T-Cell Lymphoma
How the Integration of START and CURC Is Advancing Cancer Research and Clinical Trials
How AI Transforms Early Breast Cancer Detection, and Improves Outcomes
How SkinJect's Microneedle Technology Could Transform the Treatment of Skin Cancer
How AI Innovations Are Transforming Breast Cancer Screening
The Recombinant Polyclonal Drug Candidate GIGA-2339 for Hepatitis B Treatment
How Qvin's Q-Pad Could Transform Women’s Health Through Menstrual Blood Testing
How the ARANOTE Trial Results Could Advance Prostate Cancer Treatment
Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global
The Next Generation of ADCs and the Potential of ABBV-400 in Lung Cancer Treatment
The LUMINOSITY Trial And Novel Biomarker Targets in the Future of ADCs for NSCLC
The Future of Oncolytic Viruses and Their Role in Cancer Treatment
The Role of AI in the Future of Drug Discovery: Redefining Accuracy...
Digital Health
The OVATION 2 Study and the Novel Immunotherapy IMNN-001 for Ovarian Cancer
Exploring The Potential of Cytokine Therapies to Transform Cancer Treatment
Lung Cancer Treatment for Never Smokers: The HARMONIC Phase 2 Trial and LP-300
The Role of Pharmacists in the Fight Against Liver Disease / Interview with Dr. Duggan
Pharma
Subscribe for the latest news and events
Most Popular
Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization
FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults
Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors
A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH
Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR
NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment
FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis
EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer
Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases
NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer
Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B
FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma
New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages
FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma
